-
The US has announced new tariffs on heavy trucks, steel, aluminum, and various finished goods, citing national security. The move affects European and Mexican industries, with concerns over supply chains and trade relations. The tariffs take effect from October 1, 2025, amid ongoing global trade tensions.
-
On December 1-2, 2025, WHO issued its first guidelines recommending long-term use of GLP-1 drugs like Wegovy and Mounjaro for obesity treatment, recognizing obesity as a chronic disease. The US government finalized deals lowering prices for these drugs under Medicare and Medicaid, expanding coverage to more patients. Despite benefits, studies show weight and health gains reverse if treatment stops, highlighting need for ongoing care.
-
Switzerland and the US have agreed to reduce tariffs from 39% to 15%, aligning US duties with the EU. The non-binding framework aims to ease trade tensions, boost Swiss exports, and encourage US manufacturing investments, with implementation expected soon. The deal follows months of negotiations and high-level lobbying.